Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

In the current context of the COVID-19 pandemic, it appears that our scientific resources and
the medical community are not sufficiently developed to combat rapid viral spread all over …

Objectives This study aimed to reveal the 30-year dynamics of hepatitis B virus (HBV) and
hepatitis C virus (HCV) disease burden in China from 1990-2019. Methods HBV/HCV data …

Currently, it is estimated that 1–2 million people worldwide are infected with HIV-2,
accounting for 3–5% of the global burden of HIV. The course of HIV-2 infection is longer …

Background COVID-19 patients may experience “cytokine storm” when human immune
system produces excessive cytokines/chemokines. However, it remains unclear whether …

Abstract Bictegravir (BIC), a second-generation integrase strand-transfer inhibitor (INSTI)
with high resilience to INSTI-resistance mutations, is integrated as a key component of …

Ribonucleases (RNases) cleave and process RNAs, thereby regulating the biogenesis,
metabolism, and degradation of coding and noncoding RNAs. Thus, small molecules …

Background HIV-1-associated immune activation drives CD4+ T cell depletion and the
development of acquired immunodeficiency syndrome. We aimed to determine the role of …

Lactoferrin is an 80 kDa monomeric glycoprotein that exhibits multitask activities. Lactoferrin
properties are of interest in the pharmaceutical field for the design of products with …

The COVID-19 pandemic has posed a significant threat to society in recent times,
endangering human health, life, and economic well-being. The disease quickly spreads due …